About
Cancer Diagnostic
Areas of Focus
Categories
DiagnosticsMiddle East
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
15,181
By Phase
NA: 2
By Status
COMPLETED: 5RECRUITING: 2NOT_YET_RECRUITING: 1UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06818136Lead Sponsor
Bladder EpiCheck European Haematuria Study
N/ANot yet recruiting
600 participants
Started: Apr 30, 2025 · Completed: Apr 30, 2026
NCT06245876Lead Sponsor
Lung EpiCheck Biomarkers Development Study
N/ARecruiting
6,000 participants
Started: May 17, 2022 · Completed: Dec 31, 2025
NCT04968548Lead Sponsor
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
N/ARecruiting
5,000 participants
Started: Sep 17, 2021 · Completed: Sep 30, 2025
NCT06020807Lead Sponsor
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
N/ACompleted
168 participants
Started: Sep 5, 2019 · Completed: Jan 8, 2020
NCT04264767Lead Sponsor
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA
N/ACompleted
800 participants
Started: Apr 17, 2019 · Completed: Jan 30, 2021
Locations (1)
Headquarters
Rehovot, Israel
Map
Loading map...